搜尋





搜尋





市場行情
/
股票
/
algs
/

Aligos Therapeutics Inc

ALGS

添加自選

4.230USD

-0.090-2.08%

收盤 07-31 16:00（美東）報價延遲15分鐘

26.18M總市值

虧損本益比TTM

Aligos Therapeutics Inc

4.230

-0.090-2.08%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

ALGS 利潤表

您可以在這裡找到Aligos Therapeutics Inc的年度或季度收入報告，以深入了解Aligos Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

營業總收入

809.97%2.83M

-73.13%169.00K

-41.61%741.00K

-9.05%965.00K

-68.46%311.00K

-76.54%629.00K

-60.82%1.27M

-84.59%1.06M

-63.79%986.00K

-24.20%2.68M

-21.12%3.24M

86.46%6.89M

5.91%2.72M

863.76%3.54M

167.14%4.11M

139.03%3.69M

182.53%2.57M

--367.00K

--1.54M

--910.00K

----

--0.00

營業收入

809.97%2.83M

-73.13%169.00K

-41.61%741.00K

-9.05%965.00K

-68.46%311.00K

-76.54%629.00K

-60.82%1.27M

-84.59%1.06M

-63.79%986.00K

-24.20%2.68M

-21.12%3.24M

86.46%6.89M

5.91%2.72M

863.76%3.54M

167.14%4.11M

139.03%3.69M

182.53%2.57M

--367.00K

--1.54M

--910.00K

----

--0.00

營業費用

52.19%29.76M

29.37%21.98M

35.99%29.10M

-28.91%19.53M

-15.10%19.55M

-40.95%16.99M

-3.65%21.40M

19.32%27.48M

-0.47%23.03M

9.76%28.78M

-3.66%22.21M

-4.40%23.03M

-39.31%23.14M

-31.57%26.22M

-33.38%23.05M

-22.58%24.09M

33.08%38.13M

11.75%38.31M

60.53%34.60M

46.26%31.11M

38.27%28.65M

--34.29M

--21.56M

--21.27M

--20.72M

研發費用

61.03%23.35M

6.28%17.04M

42.70%23.94M

-33.76%13.98M

-11.39%14.50M

-27.97%16.03M

5.72%16.77M

25.73%21.10M

-9.75%16.37M

16.53%22.26M

-10.81%15.87M

1.64%16.78M

-42.75%18.14M

-33.21%19.10M

-36.76%17.79M

-32.76%16.51M

38.51%31.68M

1.84%28.60M

67.39%28.13M

42.96%24.55M

32.18%22.87M

--28.08M

--16.81M

--17.18M

--17.30M

折舊攤銷及損耗

73.00%346.00K

6.64%257.00K

-26.67%220.00K

0.00%300.00K

-33.33%200.00K

-38.83%241.00K

-2.28%300.00K

-25.74%300.00K

-33.92%300.00K

-24.52%394.00K

-42.94%307.00K

-32.67%404.00K

-32.84%454.00K

-28.30%522.00K

-31.29%538.00K

-22.08%600.00K

-8.77%676.00K

-0.27%728.00K

10.59%783.00K

-19.71%770.00K

112.93%741.00K

--730.00K

--708.00K

--959.00K

--348.00K

營業利潤

-39.94%-26.93M

-33.31%-21.81M

-40.88%-28.36M

29.71%-18.57M

12.71%-19.24M

37.30%-16.36M

-6.11%-20.13M

-63.65%-26.41M

-7.97%-22.05M

-15.06%-26.10M

-0.12%-18.97M

20.85%-16.14M

42.58%-20.42M

40.23%-22.68M

42.70%-18.95M

31.02%-20.39M

-28.18%-35.56M

-10.68%-37.95M

-53.40%-33.07M

-38.99%-29.57M

-33.87%-27.74M

---34.29M

---21.56M

---21.27M

---20.72M

淨非營業利息收入（費用）

利息收入

-83.37%140.00K

74.52%548.00K

-17.29%378.00K

24.14%396.00K

45.17%842.00K

-80.24%314.00K

-54.53%457.00K

-66.60%319.00K

-22.46%580.00K

109.91%1.59M

115.67%1.00M

350.47%955.00K

769.77%748.00K

1582.22%757.00K

2230.00%466.00K

190.41%212.00K

-18.10%86.00K

-83.39%45.00K

-91.45%20.00K

-80.48%73.00K

-77.56%105.00K

--271.00K

--234.00K

--374.00K

--468.00K

利息費用

----

--1.00K

----

特殊收入（費用）

-94.48%3.40M

102.41%1.21M

---4.21M

--1.68M

--61.49M

-50432.00%-50.33M

----

--100.00K

---100.00K

---3.00M

---3.50M

----

其他非經營性收入（費用）

1665.79%671.00K

101.28%202.00K

39.72%707.00K

-97.41%811.00K

100.28%38.00K

-347.98%-15.74M

837.04%506.00K

20521.71%31.34M

-5364.96%-13.37M

-4093.18%-3.51M

129.67%54.00K

-50.00%152.00K

379.12%254.00K

-33.33%88.00K

-464.00%-182.00K

202.01%304.00K

-1616.67%-91.00K

170.97%132.00K

100.42%50.00K

-826.83%-298.00K

-97.32%6.00K

---186.00K

---11.97M

--41.00K

--224.00K

稅前利潤

-152.68%-22.72M

75.83%-19.85M

-64.24%-31.48M

-398.63%-15.68M

223.80%43.13M

-194.12%-82.12M

-6.42%-19.17M

129.11%5.25M

-52.03%-34.84M

-27.87%-27.92M

3.49%-18.01M

9.27%-18.03M

35.56%-22.92M

42.19%-21.84M

43.44%-18.66M

33.28%-19.88M

-28.71%-35.56M

-10.44%-37.77M

0.90%-33.00M

-42.84%-29.79M

-37.94%-27.63M

---34.20M

---33.30M

---20.86M

---20.03M

所得稅

637.21%317.00K

11.11%30.00K

-38.46%56.00K

-2.12%185.00K

79.17%43.00K

190.00%27.00K

213.79%91.00K

-75.03%189.00K

-38.46%24.00K

-161.22%-30.00K

167.44%29.00K

1510.64%757.00K

-26.42%39.00K

184.48%49.00K

-134.13%-43.00K

67.86%47.00K

17.78%53.00K

-126.48%-58.00K

--126.00K

147.46%28.00K

--45.00K

--219.00K

--0.00

---59.00K

--0.00

除稅後利潤

-153.47%-23.04M

75.80%-19.88M

-63.75%-31.54M

-413.44%-15.86M

223.59%43.09M

-194.53%-82.15M

-6.75%-19.26M

126.93%5.06M

-51.88%-34.86M

-27.44%-27.89M

3.11%-18.04M

5.69%-18.79M

35.55%-22.95M

41.97%-21.89M

43.78%-18.62M

33.18%-19.92M

-28.69%-35.62M

-9.57%-37.71M

0.52%-33.12M

-43.38%-29.82M

-38.17%-27.67M

---34.42M

---33.30M

---20.80M

---20.03M

持續經營利潤

-153.47%-23.04M

75.80%-19.88M

-63.75%-31.54M

-413.44%-15.86M

223.59%43.09M

-194.53%-82.15M

-6.75%-19.26M

126.93%5.06M

-51.88%-34.86M

-27.44%-27.89M

3.11%-18.04M

5.69%-18.79M

35.55%-22.95M

41.97%-21.89M

43.78%-18.62M

33.18%-19.92M

-28.69%-35.62M

-9.57%-37.71M

0.52%-33.12M

-43.38%-29.82M

-38.17%-27.67M

---34.42M

---33.30M

---20.80M

---20.03M

歸属于母公司的淨利潤

-153.47%-23.04M

75.80%-19.88M

-63.75%-31.54M

-413.44%-15.86M

223.59%43.09M

-194.53%-82.15M

-6.75%-19.26M

126.93%5.06M

-51.88%-34.86M

-27.44%-27.89M

3.11%-18.04M

5.69%-18.79M

35.55%-22.95M

41.97%-21.89M

43.78%-18.62M

33.18%-19.92M

-28.69%-35.62M

-9.57%-37.71M

0.52%-33.12M

-43.38%-29.82M

-38.17%-27.67M

---34.42M

---33.30M

---20.80M

---20.03M

歸屬普通股東的淨利潤

-153.47%-23.04M

75.80%-19.88M

-63.75%-31.54M

-413.44%-15.86M

223.59%43.09M

-194.53%-82.15M

-6.75%-19.26M

126.93%5.06M

-51.88%-34.86M

-27.44%-27.89M

3.11%-18.04M

5.69%-18.79M

35.55%-22.95M

41.97%-21.89M

43.78%-18.62M

33.18%-19.92M

-28.69%-35.62M

-9.57%-37.71M

0.52%-33.12M

-43.38%-29.82M

-38.17%-27.67M

---34.42M

---33.30M

---20.80M

---20.03M

基本每股收益

-143.22%-2.21

85.37%-1.91

0.95%-3.04

-289.49%-1.53

191.81%5.12

-20.51%-13.08

70.39%-3.07

107.44%0.81

58.27%-5.58

15.04%-10.85

4.75%-10.37

6.89%-10.87

36.14%-13.37

43.15%-12.77

44.26%-10.89

40.89%-11.67

-13.32%-20.94

4.43%-22.47

13.45%-19.53

-40.13%-19.75

-36.16%-18.48

---23.51

---22.57

---14.09

---13.57

稀釋每股收益

-4.80%-2.21

85.37%-1.91

0.95%-3.04

-289.72%-1.53

62.14%-2.11

-20.51%-13.08

70.39%-3.07

107.43%0.81

58.27%-5.58

15.04%-10.85

4.75%-10.37

6.89%-10.87

36.14%-13.37

43.15%-12.77

44.26%-10.89

40.89%-11.67

-13.32%-20.94

4.43%-22.47

13.45%-19.53

-40.13%-19.75

-36.16%-18.48

---23.51

---22.57

---14.09

---13.57

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Aligos Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 ALGS 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Aligos Therapeutics Inc 財年末的營收是多少？



Aligos Therapeutics Inc 2025 財年營收為 2.19M，高於上一財年的 3.94M。

Aligos Therapeutics Inc 最近一個季度的營收是多少？



Aligos Therapeutics Inc 最近一個季度的營收為 2.83M，同比增長 809.97%。

Aligos Therapeutics Inc 全年的淨利潤是多少？



Aligos Therapeutics Inc 2025 財年淨利潤為 -24.19M。

Aligos Therapeutics Inc 上一季度的淨利潤是多少？



Aligos Therapeutics Inc 最近一個季度的淨利潤為 -23.04M。

Aligos Therapeutics Inc 年度營業利潤是多少？



Aligos Therapeutics Inc 2025 財年的營業利潤為 -87.98M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。